The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Colangelo Dominick | Director | Grant(A) | 35K | — | $0 |
| Jun 3, 2026 | Meeker David P | Director | Grant(A) | 35K | — | $0 |
| Jun 3, 2026 | Mathers Edward T | Director | Grant(A) | 35K | — | $0 |
| Jun 3, 2026 | Heffernan Michael Thomas | Director | Grant(A) | 35K | — | $0 |
| Jun 3, 2026 | Vanlent Anne | Director | Grant(A) | 35K | — | $0 |
| Feb 19, 2026 | Simon Farrell | Chief Commercial Officer | Grant(A) | 160K | — | $0 |
| Feb 19, 2026 | Good Jennifer L | President & CEO, Director | Grant(A) | 675K | — | $0 |
| Feb 19, 2026 | Sciascia Thomas | Chief Scientific Officer | Grant(A) | 85K | — | $0 |
| Feb 19, 2026 | Galletta Christopher | See Remarks | Grant(A) | 35K | — | $0 |
| Feb 19, 2026 | Cassella James V | Chief Development Officer | Grant(A) | 215K | — | $0 |
| Jan 8, 2026 | Hastings David C | Chief Financial Officer | Grant(A) | 375K | — | $0 |
| Dec 2, 2025 | Galletta Christopher | See Remarks | Option exercise(M) | 4K | $0.51 | $2K |
| Dec 2, 2025 | Galletta Christopher | See Remarks | Option exercise(M) | 4K | — | $0 |
| Jun 11, 2025 | Meeker David P | Director | Grant(A) | 45K | — | $0 |
| Jun 11, 2025 | Vanlent Anne | Director | Grant(A) | 45K | — | $0 |
| Jun 11, 2025 | Heffernan Michael Thomas | Director | Grant(A) | 45K | — | $0 |
| Jun 11, 2025 | Colangelo Dominick | Director | Grant(A) | 45K | — | $0 |
| Jun 11, 2025 | Mathers Edward T | Director | Grant(A) | 45K | — | $0 |
| May 31, 2025 | Good Jennifer L | President & CEO, Director | Grant(A) | 102K | — | $0 |
| May 31, 2025 | Simon Farrell | Chief Commercial Officer | Grant(A) | 72K | — | $0 |
| May 31, 2025 | Delfini Lisa | Chief Financial Officer | Grant(A) | 72K | — | $0 |
| May 31, 2025 | Sciascia Thomas | Chief Scientific Officer | Grant(A) | 60K | — | $0 |
| May 31, 2025 | Galletta Christopher | See Remarks | Grant(A) | 9K | — | $0 |
| Mar 25, 2025 | Sciascia Thomas | Chief Scientific Officer | Sell(S) | 3K | $6.60 | $17K |
| Mar 25, 2025 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 3K | $1.43 | $4K |
| Mar 25, 2025 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 3K | — | $0 |
| Mar 21, 2025 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 5K | $1.43 | $8K |
| Mar 21, 2025 | Good Jennifer L | President & CEO, Director | Sell(S) | 5K | $6.58 | $35K |
| Mar 21, 2025 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 5K | — | $0 |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Sell(S) | 4K | $7.15 | $31K |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Option exercise(M) | 31K | $0.51 | $16K |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Option exercise(M) | 64K | $3.91 | $250K |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Option exercise(M) | 18K | $3.21 | $56K |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Sell(S) | 77K | $6.73 | $518K |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Option exercise(M) | 64K | — | $0 |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Option exercise(M) | 18K | — | $0 |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Grant(A) | 38K | — | $0 |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Option exercise(M) | 31K | — | $0 |
| Mar 10, 2025 | Galletta Christopher | See Remarks | Grant(A) | 5K | — | $0 |
| Mar 10, 2025 | Sciascia Thomas | Chief Scientific Officer | Grant(A) | 32K | — | $0 |
| Mar 10, 2025 | Delfini Lisa | Chief Financial Officer | Grant(A) | 38K | — | $0 |
| Mar 10, 2025 | Good Jennifer L | President & CEO, Director | Grant(A) | 54K | — | $0 |
| Feb 18, 2025 | Galletta Christopher | See Remarks | Grant(A) | 41K | — | $0 |
| Feb 18, 2025 | Good Jennifer L | President & CEO, Director | Grant(A) | 811K | — | $0 |
| Feb 18, 2025 | Delfini Lisa | Chief Financial Officer | Grant(A) | 226K | — | $0 |
| Feb 18, 2025 | Simon Farrell | Chief Commercial Officer | Grant(A) | 226K | — | $0 |
| Feb 18, 2025 | Cassella James V | Chief Development Officer | Grant(A) | 258K | — | $0 |
| Feb 18, 2025 | Sciascia Thomas | Chief Scientific Officer | Grant(A) | 116K | — | $0 |
| Jan 8, 2025 | Delfini Lisa | Chief Financial Officer | Option exercise(M) | 5K | $0.51 | $3K |
| Jan 8, 2025 | Delfini Lisa | Chief Financial Officer | Option exercise(M) | 5K | — | $0 |
| Jan 7, 2025 | Delfini Lisa | Chief Financial Officer | Option exercise(M) | 1K | $0.51 | $510 |
| Jan 7, 2025 | Delfini Lisa | Chief Financial Officer | Option exercise(M) | 1K | — | $0 |
| Dec 13, 2024 | Galletta Christopher | See Remarks | Option exercise(M) | 15K | $0.51 | $8K |
| Dec 13, 2024 | Galletta Christopher | See Remarks | Option exercise(M) | 15K | — | $0 |
| Sep 30, 2024 | Cassella James V | Chief Development Officer | Grant(A) | 400K | — | $0 |
| Sep 9, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 2K | $1.43 | $3K |
| Sep 9, 2024 | Good Jennifer L | President & CEO, Director | Sell(S) | 2K | $3.04 | $6K |
| Sep 9, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 2K | — | $0 |
| Sep 6, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 4K | $1.43 | $6K |
| Sep 6, 2024 | Good Jennifer L | President & CEO, Director | Sell(S) | 4K | $3.03 | $13K |
| Sep 6, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 4K | — | $0 |
| Sep 5, 2024 | Good Jennifer L | President & CEO, Director | Sell(S) | 40K | $3.11 | $125K |
| Sep 5, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 40K | $1.43 | $58K |
| Sep 5, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 40K | — | $0 |
| Sep 4, 2024 | Good Jennifer L | President & CEO, Director | Sell(S) | 11K | $3.02 | $33K |
| Sep 4, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 11K | $1.43 | $16K |
| Sep 4, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 11K | — | $0 |
| Sep 3, 2024 | Good Jennifer L | President & CEO, Director | Sell(S) | 4K | $3.02 | $12K |
| Sep 3, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 4K | $1.43 | $6K |
| Sep 3, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 4K | — | $0 |
| Aug 27, 2024 | Meeker David P | Director | Option exercise(M) | 5K | $1.43 | $7K |
| Aug 27, 2024 | Meeker David P | Director | Sell(S) | 5K | $2.93 | $13K |
| Aug 27, 2024 | Meeker David P | Director | Option exercise(M) | 5K | — | $0 |
| Aug 19, 2024 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 16K | $1.43 | $24K |
| Aug 19, 2024 | Sciascia Thomas | Chief Scientific Officer | Sell(S) | 16K | $2.96 | $49K |
| Aug 19, 2024 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 16K | — | $0 |
| Aug 16, 2024 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 19K | $1.43 | $27K |
| Aug 16, 2024 | Sciascia Thomas | Chief Scientific Officer | Sell(S) | 19K | $2.76 | $52K |
| Aug 16, 2024 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 19K | — | $0 |
| Aug 15, 2024 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 13K | $1.43 | $18K |
| Aug 15, 2024 | Sciascia Thomas | Chief Scientific Officer | Sell(S) | 13K | $2.79 | $36K |
| Aug 15, 2024 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 13K | — | $0 |
| Aug 14, 2024 | Sciascia Thomas | Chief Scientific Officer | Sell(S) | 100 | $2.75 | $275 |
| Aug 14, 2024 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 100 | $1.43 | $143 |
| Aug 14, 2024 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 100 | — | $0 |
| Jun 13, 2024 | Colangelo Dominick | Director | Grant(A) | 30K | — | $0 |
| Jun 13, 2024 | Meeker David P | Director | Grant(A) | 30K | — | $0 |
| Jun 13, 2024 | Heffernan Michael Thomas | Director | Grant(A) | 30K | — | $0 |
| Jun 13, 2024 | Cassella James V | Director | Grant(A) | 30K | — | $0 |
| Jun 13, 2024 | Vanlent Anne | Director | Grant(A) | 30K | — | $0 |
| Jun 13, 2024 | Mathers Edward T | Director | Grant(A) | 30K | — | $0 |
| May 29, 2024 | Sciascia Thomas | Chief Scientific Officer | Sell(S) | 53K | $2.55 | $136K |
| May 29, 2024 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 59K | $2.19 | $130K |
| May 29, 2024 | Sciascia Thomas | Chief Scientific Officer | Option exercise(M) | 59K | — | $0 |
| May 22, 2024 | Delfini Lisa | Chief Financial Officer | Option exercise(M) | 16K | $0.51 | $8K |
| May 22, 2024 | Delfini Lisa | Chief Financial Officer | Sell(S) | 4K | $2.64 | $11K |
| May 22, 2024 | Delfini Lisa | Chief Financial Officer | Option exercise(M) | 16K | — | $0 |
| May 20, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 25K | $2.19 | $55K |
| May 20, 2024 | Good Jennifer L | President & CEO, Director | Sell(S) | 25K | $2.86 | $72K |
| May 20, 2024 | Good Jennifer L | President & CEO, Director | Option exercise(M) | 25K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-20. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).